[HTML][HTML] Inhibiting the SUMO pathway represses the cancer stem cell population in breast and colorectal carcinomas
MV Bogachek, JM Park, JP De Andrade, AW Lorenzen… - Stem cell reports, 2016 - cell.com
Many solid cancers have an expanded CD44+/hi/CD24−/low cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
MV Bogachek, JM Park, JP De Andrade… - Stem cell …, 2016 - pubmed.ncbi.nlm.nih.gov
Many solid cancers have an expanded CD44+/hi/CD24-/low cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …
[引用][C] Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
MV Bogachek, JM Park, JP De Andrade… - Stem Cell …, 2016 - cir.nii.ac.jp
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and
Colorectal Carcinomas | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Colorectal Carcinomas | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
[HTML][HTML] Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
MV Bogachek, JM Park, JP De Andrade, AW Lorenzen… - Stem Cell Reports, 2016 - Elsevier
Many solid cancers have an expanded CD44+/hi/CD24−/low cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
MV Bogachek, JM Park, JP De Andrade, AW Lorenzen… - 2016 - hero.epa.gov
Many solid cancers have an expanded CD44 (+/hi)/CD24 (-/low) cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas.
MV Bogachek, JM Park, JP De Andrade… - Stem Cell …, 2016 - europepmc.org
Many solid cancers have an expanded CD44+/hi/CD24−/low cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
MV Bogachek, JM Park, JP De Andrade… - Stem Cell Reports, 2016 - infona.pl
Many solid cancers have an expanded CD44+/hi/CD24−/low cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …
[HTML][HTML] Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
MV Bogachek, JM Park, JP De Andrade… - Stem Cell …, 2016 - ncbi.nlm.nih.gov
Many solid cancers have an expanded CD44+/hi/CD24−/low cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
MV Bogachek, JM Park, JP De Andrade… - Stem cell …, 2016 - iro.uiowa.edu
Many solid cancers have an expanded CD44+/hi/CD24−/low cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas.
MV Bogachek, JM Park, JP De Andrade… - Stem Cell …, 2016 - europepmc.org
Many solid cancers have an expanded CD44+/hi/CD24−/low cancer stem cell (CSC)
population, which are relatively chemoresistant and drive recurrence and metastasis …
population, which are relatively chemoresistant and drive recurrence and metastasis …